Biotechnology AXSM FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 11, 2022
Biotechnology BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral and 2 Poster Presentations July 11, 2022
Biotechnology AXSM Final Deadline July 12: ROSEN, A TOP RANKED LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – AXSM July 10, 2022
Biotechnology AXSM FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 9, 2022
Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AXSM, OKTA and WM July 8, 2022
Biotechnology Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022 July 8, 2022
Search
Health
